癌症免疫治疗的第二个信号
Scott H Olejniczak1, Michael T Lotze2, Dimitris Skokos3
1Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA lotzemt@upmc.edu scott.olejniczak@roswellpark.org dimitris.skokos@regeneron.com.
CD28共刺激受体对于有效的癌症免疫疗法至关重要. 了解T细胞共刺激机制,包括CTLA-4和PD-1通路,对于开发新的癌症治疗方法至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- CD28受体在T细胞共刺激中起着关键作用,用于癌症免疫治疗.
- 瘤通过通过CTLA-4和PD-1等途径抑制T细胞共刺激而逃避免疫检测.
- 了解T细胞共刺激受体复杂性对于推进癌症治疗至关重要.
研究的目的:
- 要突出最近关于癌症T细胞共刺激受体的研究.
- 讨论这些研究对理解癌症免疫治疗的贡献.
主要方法:
- 评论最近的科学文献.
- 评论新出现的研究发现.
- 对T细胞共刺激机制的分析.
主要成果:
- 最近的研究揭示了癌症中T细胞共同刺激的复杂机制.
- 抑制性通路 (CTLA-4,PD-1) 是免疫逃避的关键目标.
- 替代性共同刺激策略在癌症治疗中表现有前途.
结论:
- 对CD28和其他共刺激受体的重新关注正在推动癌症免疫疗法创新.
- 针对T细胞共同刺激途径提供了治疗机会.
- 对T细胞共刺激受体的进一步研究将提高癌症治疗的疗效.
更多相关视频
08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
相关概念视频
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
